Bottom line up front: Quercetin is a plant compound with an unusually wide range of anticancer effects in lab and animal studies, but human trials proving it helps treat cancer are still lacking. It is best described as a biologically plausible, multi-target anticancer adjunct — not a proven treatment.
What Is Quercetin?
Quercetin is a plant polyphenol in the flavonol family. It is found in onions, apples, berries, capers, grapes, tea, and many leafy vegetables, and it is one of the most heavily studied dietary phytochemicals.
Researchers are interested in quercetin as a possible cancer treatment because it affects an unusually broad range of biological pathways involved in tumor growth. The lab evidence for this is extensive. The evidence from human clinical trials is much thinner.
Why Researchers Are Interested: The Big Picture
Unlike most cancer drugs, which hit a single molecular target, quercetin appears to act on many pathways at once — pathways involved in cell growth, metabolism, inflammation, programmed cell death (apoptosis), blood vessel formation (angiogenesis), and tumor spread (invasion).
In simplified terms, laboratory studies suggest quercetin can:
Suppress several growth-signaling pathways (PI3K/AKT/mTOR, STAT3/NF-κB, Wnt/β-catenin, HIF-1α/VEGF)
Alter oxidative stress inside cancer cells
Trigger cell-cycle arrest and apoptosis
Reduce glucose metabolism, blood vessel formation, and invasion
Impair the survival of cancer stem cells
This broad activity is exactly why quercetin is more often studied as part of a combination strategy rather than as a standalone treatment. [1]